Postoperative Neck Ultrasonography Surveillance After Thyroidectomy in Patients With Medullary Thyroid Carcinoma: A Multicenter Study

• Published in: Frontiers in endocrinology (Lausanne) Vol. 9; p. 102
• Main Authors: Ahn, Hye Shin, Kim, Dong Wook, Lee, Yoo Jin, Lee, Chang Yoon, Kim, Ji-Hoon, Choi, Yoon Jung, Lee, Song, Ryoo, Inseon, Huh, Jung Yin, Sung, Jin Yong, Kwak, Jin Young, Baek, Hye Jin
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 15.03.2018
• Subjects: Endocrinology; malignancy; medullary thyroid carcinoma; recurrence; surveillance; thyroid; ultrasonography; recurrence; surveillance; malignancy; thyroid; medullary thyroid carcinoma; ultrasonography
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2018.00102

For detecting tumor recurrence of medullary thyroid carcinoma (MTC) in the neck, an appropriate frequency and interval of postoperative ultrasonography (US) surveillance remains unclear. This study aimed to assess an appropriate interval and frequency of postoperative neck US surveillance for detecting tumor recurrence in patients who had undergone thyroid surgery due to MTC. A total of 86 patients who had undergone thyroid surgery for the treatment of MTC and had at least one postoperative US follow-up examination at any of nine affiliated hospitals were included. Postoperative follow-up US, clinical, and histopathological results of patients were reviewed. The tumor recurrence/persistence rate of MTC was investigated, and the interval and session number of postoperative follow-up US and clinicopathologic factors were compared between tumor recurrence/persistence and non-recurrence groups. Of the 86 patients, 22 (25.6%) showed tumor recurrence/persistence. Of the 22 patients with tumor recurrence/persistence, 11 (50%) showed structural recurrence/persistence in the neck on follow-up US. In these 11 patients, the mean interval and session number of postoperative follow-up US between initial surgery and the first US detection of recurrence/persistence was 41.3 ± 39.3 months (range, 6-128 months) and 2.6 ± 2.3 (range, 1-8), respectively. On follow-up US, 6 (54.5%, 6/11) were diagnosed with tumor recurrence/persistence within 3 years of the initial surgery. Tumor recurrence/persistence was significantly correlated with TNM stage (  < 0.001) and multiplicity/bilaterality (  = 0.013). For detecting MTC recurrence/persistence, postoperative US surveillance at 1-year intervals may be sufficient within the first 3 years after thyroid surgery, but depending on the presence of relevant risk factors, annual or biannual US surveillance may be recommendable for 4-10 years after thyroid surgery.